Mode
Text Size
Log in / Sign up

First-trimester serum retinol quintiles and pregnancy outcomes in a Chinese prospective cohort

First-trimester serum retinol quintiles and pregnancy outcomes in a Chinese prospective cohort
Photo by Andrey Khoviakov / Unsplash
Key Takeaway
Interpret first-trimester retinol associations by quintile; Q5 links to lower GDM/LBW but higher emergency cesarean risk.

This prospective cohort study enrolled 1,077 singleton pregnancies at the Department of Gynecology and Obstetrics at Shenzhen Nanshan People's Hospital between 2019 and 2020. Serum retinol was measured during the first trimester (weeks 6–13) and categorized into quintiles (Q1 ≤ 0.57 μmol/L through Q5 up to 2.50 μmol/L), with Q1 serving as the reference group. Pregnancy outcomes were captured from the hospital information system, and associations were estimated with multivariate logistic regression.

After multivariable adjustment, women in the highest retinol quintile (Q5) had significantly lower odds of gestational diabetes mellitus compared with Q1 (OR 0.50; 95% CI 0.31–0.81) and lower odds of low birth weight (OR 0.26; 95% CI 0.07–0.96). The fourth quintile (Q4), not Q5, was associated with reduced odds of small for gestational age versus Q1 (OR 0.32; 95% CI 0.12–0.82). In contrast, Q5 was associated with higher odds of emergency cesarean section relative to Q1 (OR 2.31; 95% CI 1.26–4.26).

The authors conclude that higher first-trimester maternal serum retinol is linked to lower risk of gestational diabetes mellitus and low birth weight, but higher risk of emergency cesarean section.

Key limitations include the observational, single-center design, which precludes causal inference, and the use of quintile categorization rather than continuous dose-response modeling. Absolute event rates, adjustment covariates, safety/tolerability data, and funding or conflict-of-interest disclosures were not reported in the abstract. Clinicians should interpret these quintile-specific associations cautiously and avoid extrapolating to recommendations about vitamin A supplementation in early pregnancy based on this cohort alone.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
To examine the association of serum vitamin A levels in early pregnancy with the risk of adverse pregnancy outcomes in Chinese women. This prospective cohort study was conducted in the Department of Gynecology and Obstetrics at Shenzhen Nanshan People's Hospital from 2019 to 2020. Serum retinol concentrations were measured during the first trimester (the first 6–13 weeks) of pregnancy, and pregnancy outcomes were recorded in the hospital information system. Serum retinol concentrations were categorized into the following quintiles: Q1 ≤ 0.57 μmol/L, 0.57 < Q2 ≤ 0.63 μmol/L, 0.63 < Q3 ≤ 0.69 μmol/L, 0.69 < Q4 ≤ 0.82 μmol/L, and 0.82 < Q5 ≤ 2.50 μmol/L. The participants with serum retinol concentrations in the lowest quintile were used as the reference group. Statistical analysis was performed using multivariate logistic regression. A total of 1,077 singleton pregnancies were included. After multivariable adjustment, serum retinol levels in the highest quintile (Q5) were associated with a significantly lower risk of gestational diabetes mellitus [odds ratio (OR): 0.50; 95% confidence interval (CI): 0.31–0.81]. Similarly, compared with the lowest quintile (Q1), the highest quintile (Q5) was associated with a reduced risk of low birth weight (OR: 0.26; 95% CI: 0.07–0.96). Moreover, the fourth quintile (Q4) was associated with a decreased risk of small for gestational age compared with Q1 (OR: 0.32; 95% CI: 0.12–0.82). In contrast, retinol levels in Q5 were associated with an increased risk of emergency cesarean section compared with Q1 (OR: 2.31; 95% CI: 1.26–4.26). Higher maternal serum retinol levels in the first trimester were associated with a reduced risk of gestational diabetes mellitus and low birth weight, but an increased risk of emergency cesarean section.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.